Bryan Giraudo

Bryan Giraudo

Director Financiero/CFO en GOSSAMER BIO, INC. .

Fortuna: 6 M $ al 31/08/2026

50 años
Finance
Health Technology
Consumer Services

Perfil

Bryan Giraudo is currently an Independent Director at Valerio Therapeutics SA since 2021, an Independent Director at Protagonist Therapeutics, Inc. since 2018, and Chief Financial & Operating Officer at Gossamer Bio, Inc. since 2021.
Former positions include Senior Managing Director at Leerink Partners LLC from 2009 to 2018, Managing Director at Merrill Lynch & Co., Inc. from 1997 to 2009, and Managing Director at Pierce Fenner & Smith, Inc. Education includes an undergraduate degree from Georgetown University conferred in 1997.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
08/05/2026 40.520 ( 0,06 % ) 6 M $ 31/08/2026
14/09/2026 572.880 ( 0,12 % ) 97 390 $ 31/08/2026

Cargos activos de Bryan Giraudo

EmpresasCargoInicio
PROTAGONIST THERAPEUTICS, INC. Director/Miembro de la Junta 16/05/2018
GOSSAMER BIO, INC. Director Financiero/CFO 07/05/2018
VALERIO THERAPEUTICS Director/Miembro de la Junta 23/11/2021

Antiguos cargos conocidos de Bryan Giraudo.

EmpresasCargoFin
Corporate Officer/Principal 01/05/2018
Corporate Officer/Principal 01/07/2009
Corporate Officer/Principal -
Ver el detalle de la experiencia de Bryan Giraudo.

Formación de Bryan Giraudo.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

96

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Finance

Finance

Health Technology

Consumer Services

Health Technology

Finance

Health Technology